Philip Morris International said its Board of Directors declared a regular quarterly dividend of $1.47 per common share on December 12, 2025.

8-KRegulation FD DisclosureFiled Dec 12, 2025Period of report Dec 12, 2025Summary published (UTC) Oct 12, 2026

Key points

AI summary

Philip Morris International said its Board of Directors declared a regular quarterly dividend of $1.47 per common share on December 12, 2025.
The company said the dividend is payable on January 14, 2026 to shareholders of record as of December 26, 2025. The ex-dividend date is December 26, 2025.
The company said smoke-free products accounted for 41% of 2025 first-nine months total net revenues. It estimated that as of June 30, 2025, smoke-free products were used by 41 million legal-age consumers or more around the world.
The company said it has invested over $14 billion since 2008 to develop, scientifically substantiate and commercialize innovative smoke-free products. It explained that the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Quarterly Dividend of $1.47 Per Share Declared

Philip Morris International said its Board of Directors declared a regular quarterly dividend of $1.47 per common share on December 12, 2025.

Source · Based on the filing body and exhibits

Dividend Payment Date and Record Date

The company said the dividend is payable on January 14, 2026 to shareholders of record as of December 26, 2025. The ex-dividend date is December 26, 2025.

Source · Based on the filing body and exhibits

Smoke-Free Business Share and User Count

The company said smoke-free products accounted for 41% of 2025 first-nine months total net revenues. It estimated that as of June 30, 2025, smoke-free products were used by 41 million legal-age consumers or more around the world.

Source · Based on the filing body and exhibits

Smoke-Free Product Investment and FDA Authorization

The company said it has invested over $14 billion since 2008 to develop, scientifically substantiate and commercialize innovative smoke-free products. It explained that the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.